Autor/a: Cecconi, M., Forni, G. & Mantovani, A. Fuente: Intensive Care Med (2020). https://doi.org/10.1007/s00134-020-06140-0 Ten things we learned about COVID-19
Tai W et al (2020) Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol. https://doi.org/10.1038/s41423-020-0400-4
Ferretti L et al (2020) Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing. Science. https://doi.org/10.1126/science.abb6936
Zhou F et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062
Vabret N et al (2020) Immunology of COVID-19: current state of the science. Immunity. https://doi.org/10.1016/j.immuni.2020.05.002
Sethuraman N, Jeremiah SS, Ryo A (2020) Interpreting diagnostic tests for SARS-CoV-2. JAMA. https://doi.org/10.1001/jama.2020.8259
Lodigiani C et al (2020) Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 191:9–14
Varga Z et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395(10234):1417–1418
Joly BS, Siguret V, Veyradier A (2020) Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19. Intensive Care Med. https://doi.org/10.1007/s00134-020-06088-1
WHO (2020) WHO “Immunity passports” in the context of COVID-19. https://www.who.int/news